Photo Credit: Getty/Tom Merton
The accused: Martin Shkreli, CEO of Turing Pharmaceuticals
The place: New York City
The charges: Shkreli, who became infamous after jacking up the price of a generic AIDs drug and boasting about it online, was arrested on securities fraud charges in December.
Court documents allege that Shkreli ran Turing essentially like a Ponzi scheme: After losing considerable amounts of money for investors, he would lie about the losses and pull funds from his other companies to pay the debts.
The plea: Shkreli pleaded not guilty to the charges. He resigned from his position at the head of Turing the day after his arrest, and was fired as CEO of KaloBios Pharmaceuticals.
A federal judge in Brooklyn has set his trial date for June 2017, according to CNN Money.